Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

Joseph Larmarange

Conference Papers Year :

Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

(1)

1

Joseph Larmarange

Function : Author
PersonId : 5290
IdHAL : joseph-larmarange
ORCID : 0000-0001-7097-700X
IdRef : 123902460

Centre population et développement

CV

Domains

Santé publique et épidémiologie Demography

Fichier principal

Larmarange_TasP_ANRS12249_INTEREST_2015-05.pdf (1.17 Mo)

Origin : Files produced by the author(s)
Licence : CC BY - Attribution

Joseph Larmarange : Connect in order to contact the contributor

https://hal.ird.fr/ird-04112528

Submitted on : Wednesday, May 31, 2023-5:03:18 PM

Last modification on : Tuesday, June 6, 2023-4:02:02 AM

Long-term archiving on: Friday, September 1, 2023-8:06:47 PM

Dates and versions

ird-04112528 , version 1 (31-05-2023)

Identifiers

HAL Id : ird-04112528 , version 1

Cite

Joseph Larmarange. Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial. 9th INTEREST Workshop, May 2015, Harare, Zimbabwe. ⟨ird-04112528⟩

Treatment as Prevention (TasP) studies: the challenge of CD4 count treatment eligibility changes in Africa. Perspectives from the TasP ANRS 12249 trial

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share